Skip to content

COVID Infection in Pediatric Surgical Patient

Prevalence of Asymptomatic COVID-19 Infection in Pediatric Surgical Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05898529
Enrollment
350
Registered
2023-06-12
Start date
2023-07-01
Completion date
2025-12-31
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

Children infected with COVID-19 are mostly asymptomatic. There is a dearth of data on the epidemiology of COVID-19 in the pediatric population. This is a prospective observational clinical study of pediatric surgical patients. COVID-19 rapid antigen testing will be performed on pediatric patients.

Detailed description

Children infected with COVID-19 are mostly asymptomatic or mildly symptomatic. Children may spread COVID-19 to the elderly, vulnerable patients and medical staff. There is a dearth of data on the epidemiology of COVID-19 in the pediatric surgical population. Rapid antigen detection tests for the diagnosis of COVID-19 are reliable, simple, fast, and inexpensive. This is a prospective observational clinical study. The study population will include all consenting pediatric surgical patients, aged 2-17 years. Informed consent will be obtained from each patient and the legal guardian who agree to participate in the study. Nasopharyngeal swab specimens will be collected from anesthetized pediatric patients. COVID-19 rapid antigen testing will be performed according to the equipment manufacturer's instructions. Data collection will include COVID-19 test result, nasal swab complication, patient demographics, surgical history, medical history, regular medications, COVID-19 symptoms, and COVID-19 exposure information. COVID-19 symptoms that will be recorded are cough, wheeze, nasal congestion, breathing difficulty, new loss of taste or smell, fever, chills, rigors, body aches, sore throat, nausea, and fatigue. COVID-19 exposure will be considered as being within 6 feet of a person with diagnosed COVID-19 infection in the previous 14 days.

Interventions

DIAGNOSTIC_TESTRapid antigen test

COVID-19 rapid antigen testing of nasal swab

Sponsors

Salem Anaesthesia Pain Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* surgical patients aged 2-17 years * informed consent for surgery * no COVID-19 diagnosis in previous 6 months * no history of nasal bleeding * no history of coagulopathy.

Exclusion criteria

* patient refusal of testing * difficulty in obtaining consent * COVID-19 diagnosis in recent 6 month * history of nasal bleeding * history of coagulopathy.

Design outcomes

Primary

MeasureTime frameDescription
Antigen test positive result1 dayCOVID-19 antigen test positive

Countries

Canada

Contacts

Primary ContactOlumuyiwa Bamgbade, MD,FRCPC
olu.bamgbade@gmail.com17786286600

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026